ConductScience.org, home

Comparison · NCT02205359-ede799d4

aCRT ON vs aCRT OFF: Combined Endpoint of All-cause Mortality and Intervention for Heart Failure Decompensation

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. aCRT ON vs aCRT OFF: Combined Endpoint of All-cause Mortality and Intervention for Heart Failure Decompensation. Trial comparisons, record NCT02205359-ede799d4. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02205359-ede799d4

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.2380.2190.258wilson
Risk in group 20.260.240.281wilson
Risk difference, group 1 minus group 2-0.0225-0.05070.00565newcombe hybrid score
Risk ratio, group 1 over group 20.9130.8151.02log
Odds ratio, group 1 over group 20.8860.7621.03log
Number needed to treat, for one fewer participant with the outcome on aCRT ON than on aCRT OFF44.4from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1aCRT ONThe aCRT algorithm has been developed to provide RV-synchronized LV pacing when intrinsic AV conduction is normal or BiV pacing otherwise~aCRT ON: CRT device with AdaptivCRT enabled4301,810OG000
Group 2aCRT OFFStandard CRT~aCRT OFF: CRT device with AdaptivCRT disabled4701,807OG001

Outcome

Type
PRIMARY
Title
Combined Endpoint of All-cause Mortality and Intervention for Heart Failure Decompensation
Description
The first occurrence of death or intervention for heart failure decompensation (defined as an event requiring invasive intervention or inpatient hospitalization).
Time frame
from subject randomization until the first occurrence of death or intervention for heart failure decompensation, median follow-up 4.9 years (max. follow-up 8.1 years)
Population
All randomized subjects

Source ClinicalTrials.gov

Trial

Title
AdaptResponse Clinical Trial
NCT number
NCT02205359
Phases
NA
Conditions
Heart Failure With Left Bundle Branch Block
Interventions
aCRT ON, aCRT OFF
Lead sponsor
Medtronic Cardiac Rhythm and Heart Failure
Results first posted
2023-11-29

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT02205359-ede799d4